Bridging Hospital to Home for Children with Medical Complexity and Their Families
NCT ID: NCT06599398
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2023-12-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transmural Care for Chronically Ill Children: Scientific Guidance and Evaluation of Pilot Projects
NCT06679595
Dutch Registry of Pediatric Cardiac Arrest
NCT06938009
An Enhanced Medical Home for High-Risk Chronically Ill Children
NCT02128776
Evaluation of Diagnoses and Clinical Outcomes in Children Undergoing MRI Scans
NCT06278376
Cerebral Oxygenation and Metabolism and Severe Head Injury in Paediatrics (COMetSHIP)
NCT05717647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: We hypothesize that an intermediate stay between hospital and home in the JPH will have a favourable effect on healthcare consumption, patient, parent and family-relevant quantitative outcome measures, compared to discharge directly from a hospital ward.
Objective: The primary objective of our study is to investigate whether an intermediate stay between hospital and home in the JPH lowers parental distress compared to discharge directly from a hospital ward. Furthermore, the effect on quality of life (QoL) in children and parents, growth, family functioning, impact on parental employment, parental self-efficacy, anxiety, depression, sleep disturbance, posttraumatic stress (PTSD), care satisfaction, and healthcare consumption will be assessed with and without an intermediate stay in the JPH.
Study design: Multicenter quasi-experimental prospective cohort study
Study population: Patients (term newborns up to the age of 18 years) who; (1) are admitted in the hospital with (a deterioration of) a chronic complex condition (CCC) and/or have (expected) continuous dependence on technology after discharge; (2) require specialized medical and/or allied health care after discharge; (3) are medically stable and/or have a set treatment regime and; (4) are not yet ready to be discharged home due organization-, care- or family circumstances.
Intervention (if applicable): Not applicable, since the JPH is the standard of transitional care in the Amsterdam UMC.
Main study parameters/endpoints:
Primary outcome measure at TCU/hospital discharge, 3 and 12 months of follow-up
1. Parental distress
Secondary outcome measures
2. Quality of Life of children at JPH/hospital discharge, 3 and 12 months of follow-up.
3. Growth parameters (weight, length, head circumference) at study inclusion, JPH/hospital discharge, 3 and 12 months of follow-up.
4. Impact of having a CMC on parents' Quality of Life and family functioning at JPH/hospital discharge, 3 and 12 months of follow-up
5. Impact on parental employment at 12 months of follow-up
6. Parental self-efficacy, anxiety, depression, sleep disturbance at JPH/hospital discharge, 3 and 12 months of follow-up.
7. Parental Posttraumatic Stress Disorder (PTSD) at 3 and 12 months of follow-up
8. Satisfaction of the parents with the received care at JPH/hospital discharge
9. Healthcare consumption during 12 months of follow-up
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects do not benefit personally from study participation. This non-therapeutic research with minors will have negligible risks. The main burden of participation in this study is the need to complete several questionnaires in total on three different time points. The expected required time-investment of the children and their caregivers is approximately 2.5 hours in total (around 50 minutes at 3 different time points). Furthermore, it requires time and effort from physicians to screen and patients for inclusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
The intervention group comprise patients and families who had an intermediate stay between hospital and home in the Jeroen Pit Huis (JPH)
Jeroen Pit Huis
The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.
Control groups
The control groups comprise patients and families who undergo the hospital to home transition directly from the hospital. This includes patients from the EMC, RUMC, and UMCG. Patients from the AUMC who transition directly from hospital to home without an intermediate stay in the JPH will also be included in the control group.
Jeroen Pit Huis
The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Jeroen Pit Huis
The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Admitted to the hospital with (a deterioration of) a chronic complex condition (CCC) \[30\] and/or (expected) continuous dependence on technology after discharge (see ad 2 below).
3. Expected need of specialized medical and/or allied health care after discharge
4. A stable medical condition and/or a set treatment regimen (see below ad 4)
5. Discharge home not yet possible due to organization-, care- or family circumstances (see below ad 5)
6. Have given informed consent (consenting process is described in chapter 11.2 recruitment and consent)
Ad 2 chronic complex condition Fulfils criteria of a chronic complex condition (CCC) \[30\] and/or (expected) continuous dependence on technology after discharge.
A complex chronic condition (CCC) is defined according to Feudtner et al. (1) as "any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or one organ system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center." Verlaat et al., updated the CCC list based on expert opinion \[31\]. A table of diagnosis classified as CCC can be found in appendix 1. An unknown but suspected complex and chronic condition, such as a child born with multiple congenital anomalies but lacking a unifying diagnosis, will be included.
Ad 4 stable medical condition
The patient is defined as being in a stable medical condition if there is:
1. A patent, safe airway to remain in the home situation, whether or not by means of a trachea cannula
2. Adequate respiration, whether or not by means of (intermittent) support with oxygen, non-invasive ventilation or invasive ventilation via a trachea cannula
3. A neurologically stable condition that may include temporary neurological impairments (such as seizures) not interfering (potentially life-threatening) with other vital functions such as respiration or circulation
4. Drug treatment that can be given at home where (if applicable): a nasogastric, duodenal or jejunal tube and/or a percutaneous endoscopic gastrostomy (PEG) tube is in situ, or if necessary, a 'home-proof' intravenous access is guaranteed
5. In case of enteral tube feeding, the nasogastric, duodenal or jejunal tube and/or a percutaneous endoscopic gastrostomy (PEG) tube is in situ, and the feeding schedule may be built up, reduced or variable if there are no contraindications for this. In case of parenteral feeding, the parenteral nutrition home program must be organized according to the home situation.
Ad 5 organization-, care- or family circumstances include the lack of 1 or more of the following requirements for safe discharge home:
1. A sustainable care plan using the four 'Medische Kindzorg Systeem' domains (medical, safety, development and social) has been drawn up that includes all four domains such as among others (Medical Child care System that is used in The Netherlands to structure medical child care in the home situation):
* care needs
* clear coordination of tasks and responsibilities of parents and healthcare professionals (primary, secondary and tertiary care).
2. The necessary medical and nursing care support (such as a feeding pump, adequate home care).
3. Parents know who to contact with questions about the organization of care (e.g. financial issues, wheelchair, municipality)
4. Essential medical technology is available at home and can be used for care.
5. Reimbursement of care at home is adequately arranged.
6. The house is located and furnished in such a way that the child can stay in it safely (accessibility for emergency services, telephone contact with parents, technical facilities)
Parents/informal carers are adequately trained to take care of the child in the home situation, that means that they:
7. Master care in all areas (medical, nursing, technical, psychosocial)
8. Obtain declaration of care competencies, in particular:
* assessment for somatic deterioration
* acting in emergency situations (e.g. seeking help, resuscitation and if applicable: cannula dislocation, PEG probe problems, docking of a seizure)
* realizing when to call for help and whom to call for help
9. Can obtain adequate telephone assistance (working telephone, English/Dutch speaking)
10. Are psychologically and emotionally ready to deal with new home situation (according to care professionals)
A potential subject will be excluded from participation in this study if:
1. The patient is in need of end-of-life care
2. Existence of predominantly social/family issues without serious medical problems in the index child
3. Patient with behavioural/psychiatric problems necessitating other type of care
4. Patient requiring rehabilitation medical care
5. Patients who are not directly discharged home from the hospital (except for the JPH (e.g. via de Boeg, Villa Expert Care))
6. Contagious disease that requires strict isolation
0 Minutes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Erasmus Medical Center
OTHER
Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands
UNKNOWN
University Medical Center Groningen
OTHER
UMC Utrecht
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clara van Karnebeek
Prof. dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam University Medical Centre
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Haspels HN, Mikkers MC, Knoester H, Jansen NJG, Ahout IML, Maaskant JM, van de Riet L, Haverman L, Dulfer K, Haasnoot M, Alsem MW, de Hoog M, van Woensel JBM, Joosten KFM, van Karnebeek CD; Transitional Care Unit Consortium. Bridging hospital to home for children with medical complexity and their families: an observational prospective cohort study protocol to assess the effectiveness of an innovative transitional care unit in the Netherlands (BRIDGE study). BMJ Open. 2025 Apr 19;15(4):e093693. doi: 10.1136/bmjopen-2024-093693.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRIDGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.